{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:47:55Z","timestamp":1791852475172,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903996"],"award-info":[{"award-number":["81903996"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2025ZZ2043"],"award-info":[{"award-number":["2025ZZ2043"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06343-6","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:34:50Z","timestamp":1784252090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Upregulation of PTPRO by WT1 alleviates podocyte injury in diabetic nephropathy through inhibiting the c-Abl\/p53 pathway"],"prefix":"10.1007","volume":"83","author":[{"given":"Hengjiang","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingmei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-5093","authenticated-orcid":false,"given":"Rong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"6343_CR1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","volume":"17","author":"RA DeFronzo","year":"2021","unstructured":"DeFronzo RA, Reeves WB, Awad AS (2021) Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. Nat Rev Nephrol 17:319\u2013334","journal-title":"Nat Rev Nephrol"},{"key":"6343_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41581-025-01042-0","volume":"22","author":"TW Yi","year":"2026","unstructured":"Yi TW, Sridhar VS, Scott J, Nardone M, Cherney D (2026) Next-generation therapeutics for diabetic kidney disease. Nat Rev Nephrol 22:318\u2013332","journal-title":"Nat Rev Nephrol"},{"key":"6343_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41581-024-00919-w","volume":"21","author":"S Li","year":"2025","unstructured":"Li S, Susztak K (2025) Mitochondrial dysfunction has a central role in diabetic kidney disease. Nat Rev Nephrol 21:77\u201378","journal-title":"Nat Rev Nephrol"},{"key":"6343_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41574-025-01171-3","volume":"22","author":"VM Leon","year":"2026","unstructured":"Leon VM, Hilburg R, Susztak K (2026) Mechanisms of diabetic kidney disease and established and emerging treatments. Nat Reviews Endocrinol 22:21\u201335","journal-title":"Nat Reviews Endocrinol"},{"key":"6343_CR5","doi-asserted-by":"publisher","first-page":"19953","DOI":"10.1016\/S0021-9258(17)32113-0","volume":"269","author":"PE Thomas","year":"1994","unstructured":"Thomas PE, Wharram BL, Goyal M, Wiggins JE, Holzman LB, Wiggins RC (1994) Glepp1, a Renal Glomerular Epithelial-Cell (Podocyte) Membrane Protein-Tyrosine-Phosphatase - Identification, Molecular-Cloning, and Characterization in Rabbit. J Biol Chem 269:19953\u201319961","journal-title":"J Biol Chem"},{"key":"6343_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1006\/geno.1995.1021","volume":"27","author":"RC Wiggins","year":"1995","unstructured":"Wiggins RC, Wiggins JE, Goyal M, Wharram BL, Thomas PE (1995) Molecular-Cloning of Cdnas Encoding Human Glepp1, a Membrane-Protein Tyrosine Phosphatase - Characterization of the Glepp1 Protein Distribution in Human Kidney and Assignment of the Glepp1 Gene to Human-Chromosome 12p12-P13. Genomics 27:174\u2013181","journal-title":"Genomics"},{"key":"6343_CR7","doi-asserted-by":"publisher","first-page":"9828","DOI":"10.1523\/JNEUROSCI.0729-17.2017","volume":"37","author":"W Jiang","year":"2017","unstructured":"Jiang W, Wei MP, Liu MN, Pan YL, Cao D, Yang XF, Zhang C (2017) Identification of Protein Tyrosine Phosphatase Receptor Type O (PTPRO) as a Synaptic Adhesion Molecule that Promotes Synapse Formation. J Neurosci 37:9828\u20139843","journal-title":"J Neurosci"},{"key":"6343_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000020528","volume":"6","author":"K Sharif","year":"1998","unstructured":"Sharif K, Goyal M, Kunkel R, Wiggins R (1998) Podocyte phenotypes as defined by expression and distribution of GLEPP1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS - A dedifferentiation hypothesis for the nephrotic syndrome. Exp Nephrol 6:234\u2013244","journal-title":"Exp Nephrol"},{"key":"6343_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/147323000703500308","volume":"35","author":"J Tian","year":"2007","unstructured":"Tian J, Wang HP, Mao YY, Jin J, Chen JH (2007) Reduced glomerular epithelial protein 1 expression and podocyte injury in immunoglobulin A nephropathy. J Int Med Res 35:338\u2013345","journal-title":"J Int Med Res"},{"key":"6343_CR10","first-page":"1578","volume":"26","author":"F Ozaltin","year":"2011","unstructured":"Ozaltin F, Ibsirlioglu T, Taskiran ZE, Baydar DE, Kaymaz F, Buyukcelik M, Iatropoulos P, Akarsu NA, Schaefer F, Bakkaloglu A (2011) Disruption of the ptpro gene causes childhood onset nephrotic syndrome. Pediatr Nephrol 26:1578\u20131578","journal-title":"Pediatr Nephrol"},{"key":"6343_CR11","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1172\/JCI7236","volume":"106","author":"BL Wharram","year":"2000","unstructured":"Wharram BL, Goyal M, Gillespie PJ, Wiggins JE, Kershaw DB, Holzman LB, Dysko RC, Saunders TL, Samuelson LC, Wiggins RC (2000) Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate. J Clin Invest 106:1281\u20131290","journal-title":"J Clin Invest"},{"key":"6343_CR12","unstructured":"Pattaro C, Teumer A, Gorski M, Chu AY, Li M, Mijatovic V, GarnaasM, Tin A, Sorice R, Li Y, Taliun D, Olden M, Foster M, Yang Q, Chen MH, Pers TH, Johnson AD, Ko YA, Fuchsberger C, Tayo B, Nalls M, Feitosa MF, Isaacs A, Dehghan A, d\u2019Adamo P, Adeyemo A, Dieffenbach AK, Zonderman AB, Nolte IM, van der Most PJ, Wright AF, Shuldiner AR, Morrison AC, Hofman A, Smith AV, Dreisbach AW, Franke A, Uitterlinden AG, Metspalu A, Tonjes A, Lupo A, RobinoA, Johansson A, Demirkan A, Kollerits B, Freedman BI, Ponte B, Oostra BA, Paulweber B, Kramer BK, Mitchell BD, Buckley BM, Peralta CA, Hayward C, Helmer C, Rotimi CN, Shaffer CM, Muller C, Sala C, van Duijn CM, Saint-Pierre A, Ackermann D, Shriner D, Ruggiero D, Toniolo D, Lu Y, Cusi D, Czamara D, Ellinghaus D, Siscovick DS, Ruderfer D, Gieger C, Grallert H, Rochtchina E, Atkinson EJ, Holliday EG, Boerwinkle E, Salvi E, Bottinger EP, Murgia F, Rivadeneira F, Ernst F, Kronenberg F, Hu FB, Navis GJ, Curhan GC, Ehret GB, Homuth G, Coassin S, Thun GA, Pistis G, Gambaro G, Malerba G, Montgomery GW, Eiriksdottir G, Jacobs G, Li G, Wichmann HE, Campbell H, Schmidt H, Wallaschofski H, Volzke H, Brenner H, Kroemer HK, Kramer H, Lin H, Leach IM, Ford I, Guessous I, Rudan I, Prokopenko I, Borecki I, Heid IM, Kolcic I, Persico I, Jukema JW, Wilson JF, Felix JF, Divers J, Lambert JC, Stafford JM, Gaspoz JM, SmithJA, Faul JD, Wang JJ, Ding J, Hirschhorn JN, Attia J, Whitfield JB, Chalmers J, Viikari J, Coresh J, Denny JC, Karjalainen J, Fernandes JK, Endlich K, Butterbach K, Keene KL, Lohman K, Portas L, Launer LJ, Lyytikainen LP, Yengo L, Franke L, Ferrucci L, Rose LM, Kedenko L, Rao M, Struchalin M, Kleber ME, Cavalieri M, Haun M, Cornelis MC, Ciullo M, Pirastu M, de Andrade M, McEvoy MA, Woodward M, Adam M, Cocca M, Nauck M, Imboden M, Waldenberger M, Pruijm M, Metzger M, Stumvoll M, Evans MK, Sale MM, Kahonen M, Boban M, Bochud M, Rheinberger M, Verweij N, Bouatia-Naji N, Martin NG, Hastie N, Probst-Hensch N, Soranzo N, Devuyst O, Raitakari O, Gottesman O, Franco OH, Polasek O, Gasparini P, Munroe PB, Ridker PM, Mitchell P, Muntner P, Meisinger C, Smit JH, Consortium I, Consortium A, Cardiogram CH-HF, Group EC, Consortium P, Kovacs PS, Wild P, Froguel R, Rettig R, Magi R, Biffar R, Schmidt RP, Middelberg RJ, Carroll BW, Penninx RJ, Scott R, Katz S, Sedaghat SH, Wild SL, Kardia S, Ulivi SJ, Hwang S, Enroth S, Kloiber S, Trompet B, Stengel SJ, Hancock ST, Turner SE, Rosas S, Stracke TB, Harris T, Zeller T, Zemunik T, Lehtimaki T, Illig T, Aspelund T, Nikopensius T, Esko T, Tanaka U, Gyllensten U, Volker V, Emilsson V, Vitart , Aalto V, Gudnason V, Chouraki WM, Chen W, Igl W, Marz W, Koenig W, Lieb RJ, Loos Y, Liu H, Snieder PP, Pramstaller A, Parsa JR, O\u2019Connell K, Susztak P, Hamet J, Tremblay IH, de Boer CA, Boger W, Goessling DI, Chasman A, Kottgen WH, Kao CS (2016) Fox, Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat Commun, 7:10023"},{"key":"6343_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1242\/jcs.175521","volume":"129","author":"A Khatri","year":"2016","unstructured":"Khatri A, Wang J, Pendergast AM (2016) Multifunctional Abl kinases in health and disease. J Cell Sci 129:9\u201316","journal-title":"J Cell Sci"},{"key":"6343_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/B978-0-12-385859-7.00006-9","volume":"286","author":"S Wessler","year":"2011","unstructured":"Wessler S, Backert S (2011) Abl Family of Tyrosine Kinases and Microbial Pathogenesis. Int Rev Cell Mol Biology 286:271\u2013300","journal-title":"Int Rev Cell Mol Biology"},{"key":"6343_CR15","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI122440","volume":"129","author":"B Li","year":"2019","unstructured":"Li B, He J, Lv H, Liu Y, Lv X, Zhang C, Zhu Y (2019) Ai, c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow. J Clin Invest 129:1167\u20131179","journal-title":"J Clin Invest"},{"key":"6343_CR16","doi-asserted-by":"crossref","unstructured":"Martinez A, Lamaizon CM, Valls C, Llambi F, Leal N, Fitzgerald P, Guy C, Kaminski MM, Inestrosa NC, van Zundert B, Cancino GI, Dulcey AE, Zanlungo S, Marugan JJ, Hetz C, Green DR (2023) A.R. Alvarez, c-Abl Phosphorylates MFN2 to Regulate Mitochondrial Morphology in Cells under Endoplasmic Reticulum and Oxidative Stress, Impacting Cell Survival and Neurodegeneration, Antioxidants (Basel), 12","DOI":"10.3390\/antiox12112007"},{"key":"6343_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.diabres.2015.12.013","volume":"113","author":"Y Ma","year":"2016","unstructured":"Ma Y, Yang Q, Chen X, Liang W, Ren Z, Ding G (2016) c-Abl contributes to glucose-promoted apoptosis via p53 signaling pathway in podocytes. Diabetes Res Clin Pract 113:171\u2013178","journal-title":"Diabetes Res Clin Pract"},{"key":"6343_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1091\/mbc.E15-04-0223","volume":"27","author":"Q Yang","year":"2016","unstructured":"Yang Q, Ma YQ, Liu YP, Liang W, Chen XH, Ren ZL, Wang HM, Singhal PC, Ding GH (2016) Angiotensin II down-regulates nephrin-Akt signaling and induces podocyte injury: role of c-Abl. Mol Biol Cell 27:197\u2013208","journal-title":"Mol Biol Cell"},{"key":"6343_CR19","doi-asserted-by":"publisher","first-page":"8345","DOI":"10.1523\/JNEUROSCI.0128-18.2018","volume":"38","author":"Y Yu","year":"2018","unstructured":"Yu Y, Shintani T, Takeuchi Y, Shirasawa T, Noda M (2018) Protein Tyrosine Phosphatase Receptor Type J (PTPRJ) Regulates Retinal Axonal Projections by Inhibiting Eph and Abl Kinases in Mice. J Neurosci 38:8345\u20138363","journal-title":"J Neurosci"},{"key":"6343_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000544025","volume":"50","author":"J Lu","year":"2025","unstructured":"Lu J, Zhang XH, Liu HM, Liu Y (2025) Exploring the Multifaceted Role of WT1 in Kidney Development and Disease. Kidney Blood Press R 50:176\u2013188","journal-title":"Kidney Blood Press R"},{"key":"6343_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/ki.2015.198","volume":"88","author":"LH Dong","year":"2015","unstructured":"Dong LH, Pietsch S, Englert C (2015) Towards an understanding of kidney diseases associated with mutations. Kidney Int 88:684\u2013690","journal-title":"Kidney Int"},{"key":"6343_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/353431a0","volume":"353","author":"J Pelletier","year":"1991","unstructured":"Pelletier J, Bruening W, Li FP, Haber DA, Glaser T, Housman DE (1991) Wt1 Mutations Contribute to Abnormal Genital System-Development and Hereditary Wilms-Tumor. Nature 353:431\u2013434","journal-title":"Nature"},{"key":"6343_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0092-8674(91)90194-4","volume":"67","author":"J Pelletier","year":"1991","unstructured":"Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D (1991) Germline Mutations in the Wilms-Tumor Suppressor Gene Are Associated with Abnormal Urogenital Development in Denys-Drash Syndrome. Cell 67:437\u2013447","journal-title":"Cell"},{"key":"6343_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ng1297-467","volume":"17","author":"S Barbaux","year":"1997","unstructured":"Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F, Fekete CN, SouleyreauTherville N, Thibaud E, Fellous M, McElreavey K (1997) Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 17:467\u2013470","journal-title":"Nat Genet"},{"key":"6343_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.freeradbiomed.2017.03.012","volume":"108","author":"J Wan","year":"2017","unstructured":"Wan J, Hou XY, Zhou ZM, Geng J, Tian JW, Bai XY, Nie J (2017) WT1 ameliorates podocyte injury via repression of EZH2\/\u03b2-catenin pathway in diabetic nephropathy. Free Radic Biol Med 108:280\u2013299","journal-title":"Free Radic Biol Med"},{"key":"6343_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ki.2015.140","volume":"88","author":"J Lefebvre","year":"2015","unstructured":"Lefebvre J, Clarkson M, Massa F, Bradford ST, Charlet A, Buske F, Lacas-Gervais S, Schulz H, Gimpel C, Hata Y, Schaefer F, Schedl A (2015) Alternatively spliced isoforms of WT1 control podocyte-specific gene expression. Kidney Int 88:321\u2013331","journal-title":"Kidney Int"},{"key":"6343_CR27","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1681\/ASN.2014080819","volume":"26","author":"L Dong","year":"2015","unstructured":"Dong L, Pietsch S, Tan Z, Perner B, Sierig R, Kruspe D, Groth M, Witzgall R, Grone HJ, Platzer M, Englert C (2015) Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms\u2019 Tumor 1 Target Genes in Podocyte Differentiation and Maintenance. J Am Soc Nephrol 26:2118\u20132128","journal-title":"J Am Soc Nephrol"},{"key":"6343_CR28","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.cmet.2020.10.019","volume":"32","author":"Y Fu","year":"2020","unstructured":"Fu Y, Sun Y, Wang M, Hou Y, Huang W, Zhou D, Wang Z, Yang S, Tang W, Zhen J, Li Y, Wang X, Liu M, Zhang Y, Wang B, Liu G, Yu X, Sun J, Zhang C, Yi F (2020) Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism. Cell Metab 32:1052\u20131062e1058","journal-title":"Cell Metab"},{"key":"6343_CR29","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/jcb.24525","volume":"114","author":"SH Hsu","year":"2013","unstructured":"Hsu SH, Motiwala T, Roy S, Claus R, Mustafa M, Plass C, Freitas MA, Ghoshal K, Jacob ST (2013) Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate. J Cell Biochem 114:1810\u20131818","journal-title":"J Cell Biochem"},{"key":"6343_CR30","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/jcb.22593","volume":"110","author":"T Motiwala","year":"2010","unstructured":"Motiwala T, Datta J, Kutay H, Roy S, Jacob ST (2010) Lyn kinase and ZAP70 are substrates of PTPROt in B-cells: Lyn inactivation by PTPROt sensitizes leukemia cells to VEGF-R inhibitor pazopanib. J Cell Biochem 110:846\u2013856","journal-title":"J Cell Biochem"},{"key":"6343_CR31","doi-asserted-by":"publisher","first-page":"eabc8226","DOI":"10.1126\/scitranslmed.abc8226","volume":"15","author":"WY Ding","year":"2023","unstructured":"Ding WY, Kuzmuk V, Hunter S, Lay A, Hayes B, Beesley M, Rollason R, Hurcombe JA, Barrington F, Masson C, Cathery W, May C, Tuffin J, Roberts T, Mollet G, Chu CJ, McIntosh J, Coward RJ, Antignac C, Nathwani A, Welsh GI, Saleem MA (2023) Adeno-associated virus gene therapy prevents progression of kidney disease in genetic models of nephrotic syndrome. Sci Transl Med 15:eabc8226","journal-title":"Sci Transl Med"},{"key":"6343_CR32","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41467-017-00498-4","volume":"8","author":"M Liu","year":"2017","unstructured":"Liu M, Liang K, Zhen J, Zhou M, Wang X, Wang Z, Wei X, Zhang Y, Sun Y, Zhou Z, Su H, Zhang C, Li N, Gao C, Peng J, Yi F (2017) Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. Nat Commun 8:413","journal-title":"Nat Commun"},{"key":"6343_CR33","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/gt.2014.35","volume":"21","author":"CJ Rocca","year":"2014","unstructured":"Rocca CJ, Ur SN, Harrison F, Cherqui S (2014) rAAV9 combined with renal vein injection is optimal for kidney-targeted gene delivery: conclusion of a comparative study. Gene Ther 21:618\u2013628","journal-title":"Gene Ther"},{"key":"6343_CR34","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1097\/01.ASN.0000054498.83125.90","volume":"14","author":"S Taneda","year":"2003","unstructured":"Taneda S, Pippin JW, Sage EH, Hudkins KL, Takeuchi Y, Couser WG, Alpers CE (2003) Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol 14:968\u2013980","journal-title":"J Am Soc Nephrol"},{"key":"6343_CR35","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/s41467-019-10584-4","volume":"10","author":"A Mitrofanova","year":"2019","unstructured":"Mitrofanova A, Mallela SK, Ducasa GM, Yoo TH, Rosenfeld-Gur E, Zelnik ID, Molina J, Varona Santos J, Ge M, Sloan A, Kim JJ, Pedigo C, Bryn J, Volosenco I, Faul C, Zeidan YH, Garcia Hernandez C, Mendez AJ, Leibiger I, Burke GW, Futerman AH, Barisoni L, Ishimoto Y, Inagi R, Merscher S, Fornoni A (2019) SMPDL3b modulates insulin receptor signaling in diabetic kidney disease. Nat Commun 10:2692","journal-title":"Nat Commun"},{"key":"6343_CR36","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1681\/ASN.2017020143","volume":"28","author":"C Schell","year":"2017","unstructured":"Schell C, Huber TB (2017) The Evolving Complexity of the Podocyte Cytoskeleton. J Am Soc Nephrol 28:3166\u20133174","journal-title":"J Am Soc Nephrol"},{"key":"6343_CR37","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1073\/pnas.94.5.1680","volume":"94","author":"AJ Flint","year":"1997","unstructured":"Flint AJ, Tiganis T, Barford D, Tonks NK (1997) Development of substrate-trapping mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci U S A 94:1680\u20131685","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6343_CR38","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/nar\/gkv927","volume":"44","author":"M Fischer","year":"2016","unstructured":"Fischer M, Quaas M, Steiner L, Engeland K (2016) The p53-p21-DREAM-CDE\/CHR pathway regulates G2\/M cell cycle genes. Nucleic Acids Res 44:164\u2013174","journal-title":"Nucleic Acids Res"},{"key":"6343_CR39","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/ki.2012.184","volume":"82","author":"LL Zhou","year":"2012","unstructured":"Zhou LL, Cao W, Xie C, Tian J, Zhou Z, Zhou Q, Zhu P, Li A, Liu Y, Miyata T, Hou FF, Nie J (2012) The receptor of advanced glycation end products plays a central role in advanced oxidation protein products-induced podocyte apoptosis. Kidney Int 82:759\u2013770","journal-title":"Kidney Int"},{"key":"6343_CR40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1128\/MCB.18.1.629","volume":"18","author":"AIII Niculescu","year":"1998","unstructured":"Niculescu AIII, Chen XB, Smeets M, Hengst L, Prives C, Reed SI (1998) Effects of p21\u2009<\u2009SUP>Cip1\/Waf1\u2009at both the G \/S and the G \/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 18:629\u2013643","journal-title":"Mol Cell Biol"},{"key":"6343_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","volume":"102","author":"KR Tuttle","year":"2022","unstructured":"Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, Uribarri J (2022) Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int 102:248\u2013260","journal-title":"Kidney Int"},{"key":"6343_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-physiol-020911-153238","volume":"74","author":"A Greka","year":"2012","unstructured":"Greka A, Mundel P (2012) Cell Biology and Pathology of Podocytes. Annu Rev Physiol 74:299\u2013323","journal-title":"Annu Rev Physiol"},{"key":"6343_CR43","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.kint.2017.04.022","volume":"92","author":"Y Lu","year":"2017","unstructured":"Lu Y, Ye Y, Bao W, Yang Q, Wang J, Liu Z, Shi S (2017) Genome-wide identification of genes essential for podocyte cytoskeletons based on single-cell RNA sequencing. Kidney Int 92:1119\u20131129","journal-title":"Kidney Int"},{"key":"6343_CR44","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.cellsig.2010.07.001","volume":"22","author":"T Matozaki","year":"2010","unstructured":"Matozaki T, Murata Y, Mori M, Kotani T, Okazawa H, Ohnishi H (2010) Expression, localization, and biological function of the R3 subtype of receptor-type protein tyrosine phosphatases in mammals. Cell Signal 22:1811\u20131817","journal-title":"Cell Signal"},{"key":"6343_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MNH.0000000000000376","volume":"27","author":"P Geraldes","year":"2018","unstructured":"Geraldes P (2018) Protein phosphatases and podocyte function. Curr Opin Nephrol Hypertens 27:49\u201355","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"6343_CR46","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2337\/db17-0755","volume":"67","author":"Y Pan","year":"2018","unstructured":"Pan Y, Jiang S, Hou Q, Qiu DD, Shi JS, Wang L, Chen ZH, Zhang MC, Duan AP, Qin WS, Zen K, Liu ZH (2018) Dissection of Glomerular Transcriptional Profile in Patients With Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function. Diabetes 67:717\u2013730","journal-title":"Diabetes"},{"key":"6343_CR47","doi-asserted-by":"publisher","first-page":"783370","DOI":"10.3389\/fimmu.2021.783370","volume":"12","author":"F Xie","year":"2021","unstructured":"Xie F, Dong H, Zhang H (2021) Regulatory Functions of Protein Tyrosine Phosphatase Receptor Type O in Immune Cells. Front Immunol 12:783370","journal-title":"Front Immunol"},{"key":"6343_CR48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/jb\/mvv045","volume":"158","author":"T Shintani","year":"2015","unstructured":"Shintani T, Higashi S, Takeuchi Y, Gaudio E, Trapasso F, Fusco A, Noda M (2015) The R3 receptor-like protein tyrosine phosphatase subfamily inhibits insulin signalling by dephosphorylating the insulin receptor at specific sites. J Biochem 158:235\u2013243","journal-title":"J Biochem"},{"key":"6343_CR49","doi-asserted-by":"publisher","first-page":"121292","DOI":"10.1016\/j.lfs.2022.121292","volume":"313","author":"T Shintani","year":"2023","unstructured":"Shintani T, Suzuki R, Takeuchi Y, Shirasawa T, Noda M (2023) Deletion or inhibition of PTPRO prevents ectopic fat accumulation and induces healthy obesity with markedly reduced systemic inflammation. Life Sci 313:121292","journal-title":"Life Sci"},{"key":"6343_CR50","doi-asserted-by":"publisher","first-page":"216283","DOI":"10.1016\/j.canlet.2023.216283","volume":"567","author":"H Dong","year":"2023","unstructured":"Dong H, Lin W, Du L, Yao Z, Li F, Chen S, Huang Y, Ren H, Luo Y, Cai S, Chen Y, Tang H, Qiu X, Pan Y, Huang X, Zhang D, Gao S, Yeung SJ, Zhang H (2023) PTPRO suppresses lymph node metastasis of esophageal carcinoma by dephosphorylating MET. Cancer Lett 567:216283","journal-title":"Cancer Lett"},{"key":"6343_CR51","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/onc.2016.213","volume":"36","author":"H Dong","year":"2017","unstructured":"Dong H, Ma L, Gan J, Lin W, Chen C, Yao Z, Du L, Zheng L, Ke C, Huang X, Song H, Kumar R, Yeung SC, Zhang H (2017) PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2. Oncogene 36:410\u2013422","journal-title":"Oncogene"},{"key":"6343_CR52","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1093\/brain\/awab356","volume":"144","author":"H Kim","year":"2021","unstructured":"Kim H, Shin JY, Jo A, Kim JH, Park S, Choi JY, Kang HC, Dawson VL, Dawson TM, Shin JH, Lee Y (2021) Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegeneration. Brain 144:3674\u20133691","journal-title":"Brain"},{"key":"6343_CR53","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1158\/1535-7163.MCT-20-0069","volume":"19","author":"JK Jones","year":"2020","unstructured":"Jones JK, Thompson EM (2020) Allosteric Inhibition of ABL Kinases: Therapeutic Potential in Cancer. Mol Cancer Ther 19:1763\u20131769","journal-title":"Mol Cancer Ther"},{"key":"6343_CR54","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10735-013-9505-8","volume":"44","author":"XH Chen","year":"2013","unstructured":"Chen XH, Ren ZL, Liang W, Zha DQ, Liu YP, Chen C, Singhal PC (2013) Ding, c-Abl mediates angiotensin II-induced apoptosis in podocytes. J Mol Histol 44:597\u2013608","journal-title":"J Mol Histol"},{"key":"6343_CR55","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41419-017-0225-y","volume":"9","author":"Y Ma","year":"2018","unstructured":"Ma Y, Yang Q, Zhong Z, Liang W, Zhang L, Yang Y, Ding G (2018) Role of c-Abl and nephrin in podocyte cytoskeletal remodeling induced by angiotensin II. Cell Death Dis 9:185","journal-title":"Cell Death Dis"},{"key":"6343_CR56","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1038\/s41598-025-91341-0","volume":"15","author":"X Xiong","year":"2025","unstructured":"Xiong X, Liu J, Wu X, Yao Z, Meng Y, Liu S, Chen Y, Ren H, Gao S, Qiu X, Zhang H (2025) PTPRO represses breast cancer lung metastasis by inhibiting the JAK2-YAP axis. Sci Rep 15:7065","journal-title":"Sci Rep"},{"key":"6343_CR57","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang H, Guo M, Wei H, Chen Y (2023) Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther 8:92","journal-title":"Signal Transduct Target Ther"},{"key":"6343_CR58","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41420-025-02486-w","volume":"11","author":"C Zhang","year":"2025","unstructured":"Zhang C, Guo J (2025) Cell cycle disorders in podocytes: an emerging and increasingly recognized phenomenon. Cell Death Discov 11:182","journal-title":"Cell Death Discov"},{"key":"6343_CR59","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nm.3142","volume":"19","author":"CA Gebeshuber","year":"2013","unstructured":"Gebeshuber CA, Kornauth C, Dong L, Sierig R, Seibler J, Reiss M, Tauber S, Bilban M, Wang S, Kain R, Bohmig GA, Moeller MJ, Grone HJ, Englert C, Martinez J, Kerjaschki D (2013) Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat Med 19:481\u2013487","journal-title":"Nat Med"},{"key":"6343_CR60","doi-asserted-by":"publisher","first-page":"e13634","DOI":"10.1111\/apha.13634","volume":"232","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Xu C, Ye Q, Tong L, Jiang H, Zhu X, Huang L, Lin W, Fu H, Wang J, Persson PB, Lai EY, Mao J (2021) Podocyte apoptosis in diabetic nephropathy by BASP1 activation of the p53 pathway via WT1. Acta Physiol (Oxf) 232:e13634","journal-title":"Acta Physiol (Oxf)"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06343-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06343-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06343-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:02:24Z","timestamp":1791849744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06343-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6343"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06343-6","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Animal Care Committee of Shanghai Children\u2019s Hospital and conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"375"}}